Top Markets
#1 Pleasing Gold Pleasing Gold +632.35%
#2 Islamic Coin Islamic Coin +154.16%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +46.61%
#5 DogBull DogBull +36.93%
#6 Neiro Neiro +27.33%
#7 Nockchain Nockchain +22.65%
#8 ORDI ORDI +19.28%
#9 rsERG rsERG +16.70%
#10 Monad Monad +16.28%
Coin of the day
Pleasing Gold Pleasing Gold
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Mural Oncology plc Mural Oncology plc

Mural Oncology plc

MURA
Kedudukan dalam Saham #27062
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Harga Saham
$2.04
Disegerakkan terakhir: 2025-12-09
Modal Pasaran
$35.38M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-2.39%
Negara
IE
Perdagangan Mural Oncology plc (MURA)

Kategori

Healthcare
Bilangan saham terbitan bagi Mural Oncology plc (MURA)
Bilangan saham terbitan setakat August 2026: 0
Menurut laporan kewangan terkini dan harga saham Mural Oncology plc, bilangan saham terbitan semasa ialah 0. Pada akhir August 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Mural Oncology plc (MURA) dari 2026 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH